Abstract
- How SARS-CoV-2 RVPs are used to measure neutralization quickly and easily using GFP or luciferase
- Our expanded offerings: Integral Molecular’s catalog of 65+ variant RVPs provides a growing resource to keep pace with the pandemic
- Updated FDA recommendations guide the usage of RVPs and other tools for testing emerging variants during the clinical approval process
Omicron Variant (B.1.1.529) Update
Our scientists are continuing to monitor emerging SARS-CoV-2 variants and are producing RVPs accordingly. The Omicron Variant has been designated as a variant of concern by the World Health Organization and we are in the process of making these RVPs as quickly as possible.
For more information and availability contact us.
Contact Us